
51 - 200 employees
𧬠Biotechnology
π₯ Healthcare
π¬ Science
π₯ Funding within the last year
π° Post-IPO Equity on 2026-02
Biotechnology β’ Healthcare β’ Science
Insight Molecular Diagnostics is a clinical molecular diagnostics company providing precision diagnostics for oncology and transplantation. iMDx operates CLIA-certified and CAP-accredited laboratories and focuses on accurate, clinically meaningful molecular testing to enable early detection and personalized treatment. Their specialties include molecular diagnostics, non-invasive liquid biopsy, and targeted diagnostics for lung and breast cancer, with an emphasis on accessibility and improving patient outcomes.
π‘ We watch Insight Molecular Diagnostics's careers page
Several times a day
how often we check
3
roles posted in the last 30 days
Selected: πΊπΈ United States β Remote USA.
Selected: π Date Added.
π October 15
Field Clinical Applications Specialist supporting iMDx oncology and transplant molecular diagnostic products. Providing laboratory training, assay implementation, validation, troubleshooting, and market intelligence.
πΊπΈ United States β Remote
π΅ $130k - $140k / year
π₯ Funding within the last year
π° Post-IPO Equity on 2026-02
β° Full Time
π‘ Mid-level
π Senior
π» Ghost score 7%
π October 15
Director developing commercial RUO strategies for iMDxβs oncology and transplant molecular diagnostics portfolio. Driving market intelligence, KOL relationships, Early Access Programs, and product adoption.
πΊπΈ United States β Remote
π΅ $180k - $200k / year
π₯ Funding within the last year
π° Post-IPO Equity on 2026-02
β° Full Time
π΄ Lead
π Director
π» Ghost score 7%
π October 6
Clinical Liaison driving transplant KOL engagement and market adoption for a precision diagnostics company. Building physician relationships, supporting product advocacy, and coordinating cross-functional commercial initiatives.
πΊπΈ United States β Remote
π΅ $150k - $175k / year
π₯ Funding within the last year
π° Post-IPO Equity on 2026-02
β° Full Time
π Senior
π» Ghost score 7%